Global /South Korea /Healthcare /Drug Manufacturers - General /214390
chevron_leftBack
Kyongbo Pharmaceutical Co., Ltd. logo

Kyongbo Pharmaceutical Co., Ltd.

214390
KRX: 214390 Delayed
6,650KRW -2.2%
4.38 USD
As of 16 June 2026, Kyongbo Pharmaceutical Co., Ltd. has a market cap of $107.09M USD, ranking #25062 globally and #1182 in South Korea. It ranks #2243 in the Healthcare sector, and #814 in the Drug Manufacturers - General industry.
Global Rank
25062
Country Rank
1182
Sector Rank
2243
Industry Rank
814
Key Stats
Market Cap
$107.09MUSD
162.57B KRW
Enterprise Value
$185.23MUSD
281.19B KRW
Revenue (TTM)
$173.98MUSD
264.1B KRW
EBITDA (TTM)
$11.02MUSD
16.72B KRW
Net Income (TTM)
$120.09KUSD
182.29M KRW
EBITDA Margin
6.3%
Profit Margin
0.1%
PE Ratio
891.8
PS Ratio
0.6
PB Ratio
1.1
EV/EBITDA
13.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Tae-Young Kim open_in_new
Founded
1987
Website
kbpharma.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.2% -0.1% -16% 12% 17% 25%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
214390
(주)경보제약
ISIN: KR7214390007
Shares Out.:
23.907M1 Shares Float: 9.115M2
TV:
SA:
YF:
GF:
BA:
MS:
6,650 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kyongbo Pharmaceutical Co., Ltd.

Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also provides medical devices, including portable X-ray machine and ultrasonic diagnostic equipment; and extraporeal shockwave therapy and temperature control PROBE. In addition, the company is involved in CDMO business; and research and development of Clopidogrel cardiovascular drug, Imatinlb anticancer drug, Donepezil anti-psychotic drug, Entecavir for anti-virus and infectious disease, and Esomeprazole. It also exports its products. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.16B
13.91T KRW
8K%
-
$6.79B
10.3T KRW
6K%
1958.1
$5.25B
7.97T KRW
5K%
29.9
298380
$4.97B
7.55T KRW
5K%
-
000100
$4.56B
6.92T KRW
4K%
35.9
$4.45B
6.76T KRW
4K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
711K%
38.1
JNJ
$547.28B
511K%
26.4
ABBV
$360.63B
337K%
97.4
$320.51B
256.25B CHF
299K%
19.9
AZN
$288.14B
215.59B GBP
269K%
27.6
MRK
$274.03B
256K%
15.1
chevron_leftBack